Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

Completed · Phase 2

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

The purpose of this study is to determine if a higher dose of study drug is more effective in preventing relapses in patients with Multiple Sclerosis.

Key facts

Study ID

NCT00235989

Run by

Bayer

People needed

63

Starts

2003-06-01

Expected to finish

2008-01-01

Last updated by the study team

2014-05-08

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed and dated statement of informed consent
• Completion of Protocol 307000A
• Negative serum pregnancy test results
• Agreement to adequate contraception, for female patients

You may not qualify if…

• Pregnancy or lactation
• History of alcohol or drug abuse
• Inability to administer subcutaneous injections either by self or by caregiver
• Medical, psychiatric or other conditions that compromise the patient's ability to give informed consent, to understand the patient information, to comply with the study protocol, or to complete the study
• Any significant change in the patient's medical condition after enrollment in Study 307000A which would have lead to his/her exclusion from participation that study

Where it is running

• Study site — Los Angeles, California, United States
• Study site — San Francisco, California, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Kansas City, Kansas, United States
• Study site — Louisville, Kentucky, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Reno, Nevada, United States
• Study site — Stony Brook, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — High Point, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Columbus, Ohio, United States
• Study site — Nashville, Tennessee, United States
• Study site — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.